MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.47 -0.23 (-1.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Preferred Stock Liabilities (2020 - 2021)

Updated

MoonLake Immunotherapeutics' Preferred Stock Liabilities was $115 million in Q4 2021, unchanged from $115 million a year earlier and unchanged from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

From Q4 2020 onward, MoonLake Immunotherapeutics has reported Preferred Stock Liabilities for 5 quarters.

  • In earlier years, Preferred Stock Liabilities was $115 million in FY2020.
  • Per Business Quant data, MLTX's Preferred Stock Liabilities in the three quarters before Q4 2021 was $115 million (Q3 2021), $107.26 million (Q2 2021) and $107.41 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 115.00 Mn
Sep 30, 2021 115.00 Mn
Jun 30, 2021 107.26 Mn
Mar 31, 2021 107.41 Mn
Dec 31, 2020 115.00 Mn
API Access

MoonLake Immunotherapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=MLTX&period=max&api_key=YOUR_API_KEY